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ABSTRACT
Sarcoidosis is a systemic disorder that most commonly affects the lungs. Bone involvement is rare, and spinal involvement is even more 
rare. The presence of focal lesions of the vertebrae is highly suspicious of advanced malignancy. However, malignant metastatic spread to 
the spine involves the vertebral cortex rather than the bone marrow itself, a distinction that is often missed and therefore misleading. We 
describe here a middle-aged woman with multiple focal oedematous lesions of the bone marrow suspected of being advanced malignancy 
but finally diagnosed as a rare case of spinal sarcoidosis. 
LEARNING POINTS
• This article describes a rare case of vertebral sarcoidosis.
• It emphasizes the often-missed distinction between bone marrow and cortical lesions in the diagnostic work-up of focal spinal lesions.
• It also underscores the combined use of MRI together with FDG/PET-CT in elucidating the nature of lesions confined to the bone marrow.
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CASE DESCRIPTION
A 55-year-old woman with a past medical history of right congenital hip dysplasia, Erb's palsy and a recent diagnosis of psoriasis, was referred 
to our internal medicine department with increasing right leg pain and abnormal findings on spinal MRI described as multifocal lesions with 
decreased T1–T2 signal, with enhancement after gadolinium administration (Fig. 1). There was no family or personal history of cancer, fever 
and/or or recent weight loss. Physical examination was normal apart from partial restriction of the right hip joint. 
Extensive work-up for a possible primary malignancy including blood count and chemistry, protein electrophoresis, bone marrow aspiration, 
mammography, upper and lower endoscopic GI studies, bone and thyroid scan, chest and abdominal CT scan, abdominal and pelvic US and 
gynaecological examination, did not reveal any malignancy. Levels of anti-nuclear and rheumatoid factors and antibodies to cANCA and 
pANCA were within the normal range and HLA B27 was not detected. An FDG PET/CT scan showed pathological hypermetabolic uptake in 
the vertebrae. This was followed by a biopsy from the L4 vertebra which revealed prominent intramedullary fibrosis and a non-necrotizing 
granulomatous reaction characteristic of sarcoidosis, but no evidence of mycobacterium or fungal infection. Serum angiotensin-converting 
enzyme (ACE) levels were elevated above the normal range.
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A diagnosis of sarcoidosis was made and systemic steroid therapy was initiated, resulting in complete disappearance of all spinal pathological 
uptake as demonstrated by a normal repeat FDG PET/CT scan performed 5 months after discharge. Steroid treatment was halted after the 
patient developed avascular necrosis of the femur. The 1-year follow-up after steroid cessation revealed elevated serum ACE levels and the 
reappearance of pathological findings on a spinal FDG PET/CT scan. 
Figure 1. Abnormal findings on spinal MRI
DISCUSSION 
The initial and quite rare presentation of sarcoidosis in this patient was the presence of focal oedematous lesions in the spinal bone marrow 
which were detected only by an MRI scan. Bone marrow oedema presents as excessive water signals in the marrow space on MRI. In 
most cases, histological analyses of these lesions demonstrate fibrosis, increased vascularization and lymphocytic infiltrates rather than 
oedematous changes[1]. The differential diagnosis of spinal focal lesions is very broad and the presence of spinal skeletal lytic or osteoblastic 
findings on plain radiographs or a CT scan is highly suspicious of metastatic spread and commonly triggers an extensive search for a primary 
malignancy. However, the ability of a CT scan to detect either the more common lytic or less common osteoblastic bone metastases is limited 
to the cortical bone as focal bone marrow lesions are not detected. In contrast to a CT scan, the MRI technique can detect diffuse and/or 
focal pathologies in the bone marrow, whether these pathologies remain restricted to the bone marrow or progress later to destruction of 
the cortical bone as happens in advanced metastatic spread to the skeleton[2,3]. The differential diagnosis for focal bone marrow oedematous 
lesions on MRI is extremely broad[1,4]. The number of potential pathologies can be significantly reduced when only entities with a low T1 
signal intensity, as happened in our patient, are considered and includes among others: haematopoietic and solid malignancies, metabolic 
diseases, spondyloarthropathies, infectious and granulomatous diseases such as sarcoidosis, renal osteodystrophy, and miscellaneous 
diseases such as myelofibrosis, mastocytosis, haemosiderosis, lipid storage diseases and gout[4]. In our patient, most of these pathologies 
were ruled out on clinical grounds and/or the absence of typical serology. Nevertheless, a CT-guided bone marrow aspiration biopsy was 
mandatory to completely rule out malignancy and establish the diagnosis of vertebral sarcoidosis.
It should be noted that extra-pulmonary sarcoidosis of the bone is a very rare diagnosis, and more so as an initial presentation. Case reports 
of spinal sarcoidosis have been reported since the 1950s[5–11]. However, in all of these reports the first presentation was systemic disease 
affecting multiple organs rather than bone involvement. Obviously, advanced imaging modalities such as MRI were not used in many of 
the older reports and it remains unknown if and when involvement of bone marrow did occur. Thus, our case is unique in that it is the 
first description of bone marrow focal oedematous lesions due to sarcoidosis restricted to the bone marrow alone as a first manifestation, 
without any other organ involvement. 
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It is also of interest that FDG-PET/CT is highly sensitive for detecting granulomatous bone marrow infiltration[12,13]. This modality being 
increasingly used as a diagnostic tool that strengthens the diagnosis of sarcoidosis and for follow-up after treatment.
In conclusion, this rare case of vertebral sarcoidosis emphasizes the often missed but very significant distinction between bone marrow 
and cortical lesions in the diagnostic work-up of focal spinal lesions. It also underscores the combined use of MRI together with FDG/PET-
CT in elucidating the nature of lesions confined to the bone marrow. Finally, the diagnosis of bone sarcoidosis is uncommon, but should be 
kept in mind even as a lone presentation. It should also be noted that in view of the ever-increasing use of MRI as an imaging modality, that 
this diagnosis will likely become a lot more common, as did other lesions detected on MRI. The clinical significance of these MRI findings is 
uncertain and has to be determined.
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